What are the signs and symptoms of Acinetobacter baumannii infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs and Symptoms of Acinetobacter baumannii Infection

Acinetobacter baumannii infections primarily manifest as healthcare-associated infections with clinical presentations varying by site of infection, most commonly affecting critically ill patients in intensive care units. 1, 2

Common Clinical Manifestations

Pneumonia/Ventilator-Associated Pneumonia

  • Most common manifestation in intensive care settings, particularly in mechanically ventilated patients 3
  • Presents with respiratory deterioration, purulent secretions, and radiographic infiltrates 1
  • Often occurs in patients with prolonged mechanical ventilation 4

Bloodstream Infections

  • Range from transient bacteremia to severe septic shock 1
  • Clinical manifestations are non-specific and similar to bacteremia caused by other pathogens 5
  • Most common sources are intravascular catheters and respiratory tract 5
  • Associated with high crude mortality rates (30-75%) 4

Central Nervous System Infections

  • Post-neurosurgical meningitis/ventriculitis 1
  • Presents with fever, altered mental status, meningeal signs, and CSF abnormalities 1
  • May occur following neurosurgical procedures or trauma 1

Wound and Soft Tissue Infections

  • Common in surgical sites and traumatic wounds 6
  • Presents with local inflammation, purulent discharge, and delayed healing 2
  • Often seen in burn patients and following traumatic injuries 3

Urinary Tract Infections

  • Less common manifestation 6
  • Usually associated with urinary catheterization or instrumentation 5
  • Presents with typical UTI symptoms (dysuria, frequency, cloudy urine) 2

Risk Factors for A. baumannii Infection

  • Prolonged ICU stay 4
  • Mechanical ventilation 3
  • Recent invasive procedures 5
  • Prior broad-spectrum antimicrobial therapy 4
  • Presence of indwelling devices (central venous catheters, urinary catheters) 5
  • Immunocompromised state 2

Distinguishing Colonization from Infection

  • A. baumannii can form biofilms and colonize surfaces without causing infection 1
  • Isolation from clinical specimens may represent colonization rather than true infection 5
  • Clinical evaluation is essential to differentiate colonization from infection to avoid unnecessary treatment 5

Common Sites for Surveillance Cultures

  • Nose, throat, axilla, groin, rectum, open wounds, and endotracheal aspirates 1
  • Single-site cultures (e.g., nasal) have low sensitivity (13-29%) 1
  • Multi-site sampling increases detection sensitivity to approximately 50% 1

Special Considerations

  • A. baumannii has a propensity to cause outbreaks and become endemic in healthcare settings 1
  • Multidrug-resistant (MDR), extensively drug-resistant (XDR), or pandrug-resistant (PDR) strains are increasingly common, complicating treatment 6
  • Environmental persistence contributes to nosocomial spread and outbreaks 1
  • Community-acquired infections are rare but may occur in patients with comorbidities such as diabetes, chronic lung disease, or immunosuppression 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Infections Due to Acinetobacter baumannii in the ICU: Treatment Options.

Seminars in respiratory and critical care medicine, 2017

Research

Infections due to Acinetobacter baumannii in the ICU.

Seminars in respiratory and critical care medicine, 2003

Research

Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2002

Research

Treatment of Acinetobacter infections.

Expert opinion on pharmacotherapy, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.